Quest for the right Drug

|
עמוד הבית / פיקטו % 0.05 / מידע מעלון לרופא

פיקטו % 0.05 PICATO 0.05% (INGENOL MEBUTATE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

חיצוני : TOPICAL

צורת מינון:

ג'ל : GEL

Posology : מינונים

4.2     Posology and method of administration

Posology
Actinic keratosis on the trunk and extremities in adults
One tube of Picato 500 mcg/g gel (containing 235 mcg ingenol mebutate) should be applied once daily to the affected area for 2 consecutive days.

Optimal therapeutic effect can be assessed approximately 8 weeks after treatment.

A repeat treatment course of Picato can be given if an incomplete response is seen at a follow- up examination after 8 weeks or if lesions that are cleared at this examination recur in subsequent examinations.

Paediatric population
There is no relevant use of Picato in the paediatric population.

Elderly population
No dose adjustment is required (see section 5.1).
Immunocompromised patients
Clinical data on treatment in immunocompromised patients is not available, but systemic risks are not expected since ingenol mebutate is not absorbed systemically.

Method of administration
The content of one tube covers a treatment area of 25 cm2 (e.g. 5 cm x 5 cm). The tube is for single use only and should be discarded after use (see section 6.6).

The gel from the tube should be squeezed onto a fingertip and spread evenly over the entire treatment area, allowing it to dry for 15 minutes. The content of one tube should be used for one treatment area of 25 cm2.
For single use only.

For treatment of the neck:
If more than half of the treatment area is located in the upper part of the neck, Picato 150 mcg/g gel should be used at the posology for face and scalp. If more than half of the treatment area is located in the lower part of the neck, Picato 500 mcg/g gel should be used at the posology for trunk and extremities.

If an area on the face or scalp and another area on the trunk or extremities are simultaneously treated, then patients should be advised to ensure they use the appropriate strengths. Care should be exercised not to apply the Picato 500 mcg/g gel on the face or scalp as this could lead to a higher incidence of local skin responses.

Patients should be instructed to wash their hands with soap and water, immediately after applying Picato and between topical applications if two different areas require different strengths. If treating the hands, only the fingertip which is used for applying the gel should be washed.
Washing and touching the treated area should be avoided for a period of 6 hours after application of Picato. After this period, the treatment area may be washed using mild soap and water.

Picato should not be applied immediately after taking a shower or less than 2 hours before bedtime.

The treated area should not be covered with occlusive bandages after Picato is applied.

פרטי מסגרת הכללה בסל

א. התרופה תינתן לטיפול מקומי במבוגרים הסובלים מ-Actinic keratosis בחולים המוגדרים בסיכון גבוה (סובלים מלפחות 6 נגעים, הניתנים להבחנה, באזור גוף אחד או שדה וב- Field cancerization).ב. מתן התרופה האמורה ייעשה לפי מרשם של מומחה ברפואת עור ומין.
שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל 12/01/2017
הגבלות תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת

בעל רישום

DEXCEL LTD, ISRAEL

רישום

151 38 33889 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

04.09.17 - עלון לרופא

עלון מידע לצרכן

14.11.17 - עלון לצרכן אנגלית 14.11.17 - עלון לצרכן עברית 14.11.17 - עלון לצרכן ערבית 15.08.16 - החמרה לעלון 05.02.17 - החמרה לעלון

לתרופה במאגר משרד הבריאות

פיקטו % 0.05

קישורים נוספים

RxList WebMD Drugs.com